{"transactions":[{"id":1967232,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:08:25.000Z","date":"2023-03-05","kind":"exercise","acquired":false,"shares":5710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 5, 2021, with 5,710 vested on each of March 5, 2022 and March 5, 2023, 5,710 vesting on March 5, 2024, and 5,712 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 5, 2021, with 5,710 vested on each of March 5, 2022 and March 5, 2023, 5,710 vesting on March 5, 2024, and 5,712 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":11422,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5710},"source":{"system":"sec-edgar","filing":"0001209191-23-016708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016708/doc4.xml","form_type":"4"}},{"id":1967231,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:08:25.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":20107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025, and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025, and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":60321,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20107},"source":{"system":"sec-edgar","filing":"0001209191-23-016708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016708/doc4.xml","form_type":"4"}},{"id":1967230,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:08:25.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":59760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":59760,"derivative":{"underlying":"Ordinary Shares","underlying_shares":59760},"source":{"system":"sec-edgar","filing":"0001209191-23-016708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016708/doc4.xml","form_type":"4"}},{"id":1967229,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:08:25.000Z","date":"2023-03-05","kind":"exercise","acquired":true,"shares":5710,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":46011,"source":{"system":"sec-edgar","filing":"0001209191-23-016708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016708/doc4.xml","form_type":"4"}},{"id":1967228,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:08:25.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":20107,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":40301,"source":{"system":"sec-edgar","filing":"0001209191-23-016708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016708/doc4.xml","form_type":"4"}},{"id":1981779,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-03-02T12:35:22.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":4828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 28, 2020 with 4,828 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 4,829 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 28, 2020 with 4,828 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 4,829 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":4829,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4828},"source":{"system":"sec-edgar","filing":"0001209191-23-014438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014438/doc4.xml","form_type":"4"}},{"id":1981778,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:35:22.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":4828,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":20194,"source":{"system":"sec-edgar","filing":"0001209191-23-014438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014438/doc4.xml","form_type":"4"}},{"id":2345911,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:09:06.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":5710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 5, 2021, with 5,710 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and\n5,712 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 5, 2021, with 5,710 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and\n5,712 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17132,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5710},"source":{"system":"sec-edgar","filing":"0001209191-22-017051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017051/doc4.xml","form_type":"4"}},{"id":2345910,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:09:06.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":80428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80428,"derivative":{"underlying":"Ordinary Shares","underlying_shares":80428},"source":{"system":"sec-edgar","filing":"0001209191-22-017051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017051/doc4.xml","form_type":"4"}},{"id":2345909,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:09:06.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":5710,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":15366,"source":{"system":"sec-edgar","filing":"0001209191-22-017051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017051/doc4.xml","form_type":"4"}},{"id":2363038,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2022-03-02T12:48:22.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":4828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 28, 2020, with 4,828 having vested on each of February 28, 2021 and February 28, 2022,\n4,828 vesting on February 28, 2023 and 4,829 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 28, 2020, with 4,828 having vested on each of February 28, 2021 and February 28, 2022,\n4,828 vesting on February 28, 2023 and 4,829 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":9657,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4828},"source":{"system":"sec-edgar","filing":"0001209191-22-014470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014470/doc4.xml","form_type":"4"}},{"id":2363037,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":115882,"kind":"person","name":"Inbar Galia","position":1,"cik":"0001878086","reported_name":"Inbar Galia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:48:22.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":4828,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":9656,"source":{"system":"sec-edgar","filing":"0001209191-22-014470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014470/doc4.xml","form_type":"4"}}]}